新型秋水仙碱衍生的三唑类化合物及其对细胞毒性和微管形态的影响。
New Colchicine-Derived Triazoles and Their Influence on Cytotoxicity and Microtubule Morphology.
作者信息
Thomopoulou Persefoni, Sachs Julia, Teusch Nicole, Mariappan Aruljothi, Gopalakrishnan Jay, Schmalz Hans-Günther
机构信息
Department of Chemistry, University of Cologne , Greinstr. 4, 50939 Cologne, Germany.
Technische Hochschule Koeln, Kaiser-Wilhelm-Allee , Building E39, 51373 Leverkusen, Germany.
出版信息
ACS Med Chem Lett. 2015 Dec 29;7(2):188-91. doi: 10.1021/acsmedchemlett.5b00418. eCollection 2016 Feb 11.
Abstract
A series of new colchicinoids with a variable triazole unit at C-7 was synthesized through Cu(I)-catalyzed 1,3-dipolar cycloaddition (click-chemistry) of a colchicine-derived azide with various alkynes and the cytotoxicity against THP-1 and Jurkat cancer cell lines was used for structural optimization. Three particularly active compounds (IC50 ≤ 5 nM) were additionally investigated with respect to their efficacy against relevant solid tumor cell lines (HeLa, A549, and SK MES 1). Besides distorting the microtubule morphology by tubulin depolymerization, one compound also exhibited a pronounced centrosome declustering effect in triple negative breast cancer cells (MDA-MB-231) and nonsmall cell lung cancer cells (H1975).
摘要
通过秋水仙碱衍生的叠氮化物与各种炔烃的铜（I）催化的1,3-偶极环加成反应（点击化学）合成了一系列在C-7位具有可变三唑单元的新型秋水仙碱类似物，并将其对THP-1和Jurkat癌细胞系的细胞毒性用于结构优化。另外，针对三种特别活跃的化合物（IC50≤5 nM）对相关实体瘤细胞系（HeLa、A549和SK MES 1）的疗效进行了研究。除了通过微管蛋白解聚使微管形态畸变外，一种化合物在三阴性乳腺癌细胞（MDA-MB-231）和非小细胞肺癌细胞（H1975）中还表现出明显的中心体去簇集效应。
相似文献
1
New Colchicine-Derived Triazoles and Their Influence on Cytotoxicity and Microtubule Morphology.新型秋水仙碱衍生的三唑类化合物及其对细胞毒性和微管形态的影响。
ACS Med Chem Lett. 2015 Dec 29;7(2):188-91. doi: 10.1021/acsmedchemlett.5b00418. eCollection 2016 Feb 11.
2
A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.新型N-芳基三唑和N-吖啶基三唑杂化物系列作为潜在抗癌剂
Curr Org Synth. 2019;16(6):900-912. doi: 10.2174/1570179416666190704112904.
3
Click chemistry based multicomponent approach in the synthesis of spirochromenocarbazole tethered 1,2,3-triazoles as potential anticancer agents.点击化学的多组分方法在螺色烯并咔唑连接的 1,2,3-三唑作为潜在抗癌药物的合成中的应用。
Bioorg Chem. 2019 Apr;85:475-486. doi: 10.1016/j.bioorg.2019.01.070. Epub 2019 Feb 8.
4
7-Chloroquinolinotriazoles: synthesis by the azide-alkyne cycloaddition click chemistry, antimalarial activity, cytotoxicity and SAR studies.7-氯喹啉并三唑类化合物：通过叠氮-炔环加成点击化学合成、抗疟活性、细胞毒性和 SAR 研究。
Eur J Med Chem. 2014 Feb 12;73:295-309. doi: 10.1016/j.ejmech.2013.11.022. Epub 2013 Dec 1.
5
Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).从 Commiphora mukul 树胶树脂中分离出的麦鲁酮 B 的一些新型 1,2,3-三唑杂合体的合成与生物评价：鉴定对前列腺癌细胞（PC-3）具有有效抗增殖作用的潜在先导化合物。
Eur J Med Chem. 2020 Feb 15;188:111974. doi: 10.1016/j.ejmech.2019.111974. Epub 2019 Dec 18.
6
Design and synthesis of imidazo[2,1-b]thiazole linked triazole conjugates: Microtubule-destabilizing agents.咪唑并[2,1-b]噻唑连接的三唑共轭物的设计与合成：微管破坏剂
Eur J Med Chem. 2017 Jan 27;126:36-51. doi: 10.1016/j.ejmech.2016.09.060. Epub 2016 Sep 20.
7
3-Aryl/Heteroaryl-5-amino-1-(3',4',5'-trimethoxybenzoyl)-1,2,4-triazoles as antimicrotubule agents. Design, synthesis, antiproliferative activity and inhibition of tubulin polymerization.3-芳基/杂芳基-5-氨基-1-(3',4',5'-三甲氧基苯甲酰基)-1,2,4-三唑类化合物作为微管蛋白抑制剂。设计、合成、抗增殖活性及对微管蛋白聚合的抑制作用。
Bioorg Chem. 2018 Oct;80:361-374. doi: 10.1016/j.bioorg.2018.06.037. Epub 2018 Jun 30.
8
Design and synthesis of 1,2,3-triazolo-phenanthrene hybrids as cytotoxic agents.作为细胞毒性剂的1,2,3-三唑并菲杂化物的设计与合成
Bioorg Med Chem Lett. 2017 Jun 1;27(11):2369-2376. doi: 10.1016/j.bmcl.2017.04.022. Epub 2017 Apr 7.
9
Synthesis of 1,4-disubstituted 1,2,3-triazole Derivatives Using Click Chemistry and their Src Kinase Activities.利用点击化学合成1,4-二取代-1,2,3-三唑衍生物及其Src激酶活性
Med Chem. 2016;13(1):40-48. doi: 10.2174/1573406412666160404125718.
10
Design, synthesis and antiproliferative activity of functionalized flavone-triazole-tetrahydropyran conjugates against human cancer cell lines.功能化黄酮-三唑-四氢吡喃共轭物对人癌细胞系的设计、合成及抗增殖活性
Eur J Med Chem. 2014 Jul 23;82:552-64. doi: 10.1016/j.ejmech.2014.06.009. Epub 2014 Jun 6.
引用本文的文献
1
Revitalizing Colchicine: Novel Delivery Platforms and Derivatives to Expand Its Therapeutic Potential.重振秋水仙碱：拓展其治疗潜力的新型给药平台与衍生物
Int J Mol Sci. 2025 Aug 6;26(15):7591. doi: 10.3390/ijms26157591.
2
Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors.小檗碱及其他呼吸链抑制剂引发的神经毒性相关代谢特征的定义。
Antioxidants (Basel). 2023 Dec 28;13(1):49. doi: 10.3390/antiox13010049.
3
Molecular Hybridization of Alkaloids Using 1,2,3-Triazole-Based Click Chemistry.利用基于 1,2,3-三氮唑的点击化学进行生物碱的分子杂交。
Molecules. 2023 Nov 14;28(22):7593. doi: 10.3390/molecules28227593.
4
L. root extract promotes apoptosis and cell cycle arrest, inhibits epithelial-to-mesenchymal transition and triggers E-cadherin expression in breast cancer cell lines.L.根提取物可促进乳腺癌细胞系的凋亡和细胞周期停滞，抑制上皮-间质转化并触发E-钙黏蛋白表达。
3 Biotech. 2023 Feb;13(2):41. doi: 10.1007/s13205-023-03461-x. Epub 2023 Jan 10.
5
Design, Synthesis, and Antitumor Activity of Erlotinib Derivatives.厄洛替尼衍生物的设计、合成及抗肿瘤活性
Front Pharmacol. 2022 Apr 20;13:849364. doi: 10.3389/fphar.2022.849364. eCollection 2022.
6
Terminally differentiated osteoclasts organize centrosomes into large clusters for microtubule nucleation and bone resorption.终末分化的破骨细胞将中心体组织成大的簇状结构，用于微管的核形成和骨吸收。
Mol Biol Cell. 2022 Jul 1;33(8):ar68. doi: 10.1091/mbc.E22-03-0098. Epub 2022 May 5.
7
Using Polyacrylamide Hydrogels to Model Physiological Aortic Stiffness Reveals that Microtubules Are Critical Regulators of Isolated Smooth Muscle Cell Morphology and Contractility.使用聚丙烯酰胺水凝胶模拟生理主动脉僵硬度表明，微管是孤立平滑肌细胞形态和收缩性的关键调节因子。
Front Pharmacol. 2022 Jan 27;13:836710. doi: 10.3389/fphar.2022.836710. eCollection 2022.
8
Synthesis and Antitumor Activity of Erlotinib Derivatives Linked With 1,2,3-Triazole.与1,2,3-三唑相连的厄洛替尼衍生物的合成及其抗肿瘤活性
Front Pharmacol. 2022 Jan 17;12:793905. doi: 10.3389/fphar.2021.793905. eCollection 2021.
9
B-nor-methylene Colchicinoid PT-100 Selectively Induces Apoptosis in Multidrug-Resistant Human Cancer Cells via an Intrinsic Pathway in a Caspase-Independent Manner.B-去甲-亚甲基秋水仙碱类似物PT-100通过非半胱天冬酶依赖的内源性途径选择性诱导多药耐药人类癌细胞凋亡。
ACS Omega. 2022 Jan 11;7(3):2591-2603. doi: 10.1021/acsomega.1c04659. eCollection 2022 Jan 25.
10
Regioselective approach to colchiceine tropolone ring functionalization at C(9) and C(10) yielding new anticancer hybrid derivatives containing heterocyclic structural motifs.区域选择性方法对秋水仙堿托品酮环在 C(9)和 C(10)上的功能化，得到含有杂环结构基序的新型抗癌杂合衍生物。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):597-605. doi: 10.1080/14756366.2022.2028782.
本文引用的文献
1
Hitting the brakes: targeting microtubule motors in cancer.踩下刹车：靶向癌症中的微管动力蛋白
Br J Cancer. 2015 Sep 1;113(5):693-8. doi: 10.1038/bjc.2015.264. Epub 2015 Jul 16.
2
EGFR inhibitor and chemotherapy combinations for acquired TKI resistance in EGFR-mutant NSCLC models.表皮生长因子受体（EGFR）抑制剂与化疗联合用于EGFR突变的非小细胞肺癌（NSCLC）模型中获得性酪氨酸激酶抑制剂（TKI）耐药的情况
Med Oncol. 2015 Jul;32(7):205. doi: 10.1007/s12032-015-0627-6. Epub 2015 Jun 17.
3
Lipophilic prodrugs of a triazole-containing colchicine analogue in liposomes: biological effects on human tumor cells.脂质体中含三唑的秋水仙碱类似物的亲脂性前药：对人肿瘤细胞的生物学效应
Bioorg Khim. 2013 Sep-Oct;39(5):609-18.
4
Design and synthesis of pironetin analogue/colchicine hybrids and study of their cytotoxic activity and mechanisms of interaction with tubulin.皮洛酮类似物/秋水仙碱杂合体的设计与合成及其与微管蛋白相互作用的细胞毒性活性和机制研究。
J Med Chem. 2014 Dec 26;57(24):10391-403. doi: 10.1021/jm501112q. Epub 2014 Dec 12.
5
Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells.中心体去簇集药物对超中心体癌细胞的间期和有丝分裂进行双管齐下的攻击。
Cell Death Dis. 2014 Nov 20;5(11):e1538. doi: 10.1038/cddis.2014.505.
6
Cell Cycle Regulation of the Centrosome and Cilium.中心体与纤毛的细胞周期调控
Drug Discov Today Dis Mech. 2013 Dec 1;10(3-4):e119-e124. doi: 10.1016/j.ddmec.2013.03.002.
7
Oncogene-like induction of cellular invasion from centrosome amplification.从中心体扩增诱导的癌基因样细胞侵袭。
Nature. 2014 Jun 5;510(7503):167-71. doi: 10.1038/nature13277. Epub 2014 Apr 13.
8
Unusual tubulin-clustering ability of specifically c7-modified colchicine analogues.特异性 c7 修饰的秋水仙碱类似物具有异常的微管蛋白聚集能力。
Chembiochem. 2013 Aug 19;14(12):1444-9. doi: 10.1002/cbic.201300143. Epub 2013 Jul 10.
9
Tubulin inhibitors: a patent survey.微管蛋白抑制剂：专利调查。
Recent Pat Anticancer Drug Discov. 2014 May;9(2):176-220. doi: 10.2174/15748928113089990042.
10
The colchicine derivative CT20126 shows a novel microtubule-modulating activity with apoptosis.秋水仙碱衍生物 CT20126 表现出新型的微管调节活性和细胞凋亡。
Exp Mol Med. 2013 Apr 19;45(4):e19. doi: 10.1038/emm.2013.38.
Zotero 插件